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This document represents a summary of discussion, conclusions, and recommendations of an 
Expert Scientific Panel convened to: 1) provide a synopsis of chronic wasting disease (CWD) in 
free-living cervids in Canada, 2) evaluate the ecological and socio-economic implications of 
CWD in Canada, and 3) make recommendations on research and management actions to 
minimize and mitigate the effects of CWD in cervid species.  
 
The emergence of chronic wasting disease, a transmissible spongiform encephalopathy 
potentially affecting mule deer, white-tailed deer and elk, is arguably the most important issue 
in the management of free-living cervids in North America.  The disease has the potential to 
reduce cervid populations in the long-term, and to create major socio-economic impacts as 
observed in other areas in North America. 
 
CWD has been detected in western Canada only recently, first in 1996 in farmed cervids and 
subsequently in 2000 in free-living cervids in Saskatchewan.  Epidemiological investigations 
and surveillance programs of farmed cervids identified 40 game farms in Saskatchewan and 3 
game farms in Alberta with the disease. CWD is thought to have been introduced into farmed 
cervids in Saskatchewan during the late 1980s by the importation of CWD-infected elk from 
South Dakota. Management programs to eradicate the disease in farmed cervids appear to have 
been successful and there are currently no known infected farms in Canada. Environmental 
contamination of some CWD-infected premises continues to pose a potential threat to wildlife. 
Of most significance, the presence of CWD in wild deer in some areas is a potential source of 
infection for farmed cervids and poses a continued threat to the long-term economical viability 
of cervid farming. 
 
In Canada, CWD in free-living cervids appears restricted to three relatively distinct geographic 
foci in Saskatchewan, although surveillance efforts in many areas are inadequate to detect the 
disease at low prevalence.  Hence, the disease may yet be detected in other areas.  Intense, risk-
based surveillance to determine the distribution of this disease should be a high priority over the 
next few years. Demonstration of a more widespread distribution of CWD within Saskatchewan 
or elsewhere in Canada would affect management response to this disease. 
 
Results over the last two years in the Saskatchewan Landing area, Saskatchewan, indicate CWD 
is well established in the local mule deer population.  In spite of initial attempts to reduce deer 
densities by increasing hunting harvest, deer densities in most areas of western Canada are more 
than sufficient to allow CWD to spread and increase in prevalence.  
 
The range of species that may be infected with CWD is not known with certainty. Information 
from the USA would indicate all mule deer, white-tailed deer and elk are susceptible to the 
disease.  Infection in moose has been recently confirmed experimentally, but similar data for 
caribou are not available. CWD does not appear to pose a risk to cattle or bison. The risk to 
humans appears to be extremely low. Nonetheless, the World Health Organization and other 





The panel concludes that the emergence of CWD in free-living mule deer and white-tailed deer 
in Saskatchewan warrants an aggressive regional and national management and research 
response to prevent further spread of CWD and to control or eliminate the disease in wild 
cervids.  The recent introduction of CWD in Canada, and its restricted distribution, provides us 
with a unique opportunity to manage CWD before it is too late.  
Once established in a population of free-living cervids, control or eradication of CWD is 
extremely difficult.  Preventing establishment of new foci of CWD should be given the highest 
priority, which entails preventing the movement of CWD-infected cervids and infectious 
material to new areas. To prevent natural spread from endemic areas, and to reduce potential 
environmental contamination with infectious prions, severe population reductions of deer, to 
levels of <1 animal/km2 of critical habitat, will likely be required for at least a decade.  
Complete removal of deer in local areas may eliminate focal introductions of CWD.  Deer 
densities that can prevent spread of CWD, and sizes of buffer zones to contain CWD, are largely 
unknown at this time. Management programs will need to be developed using a research 
framework, and updated as we learn about this disease. 
 
Canada is at a critical juncture in its response to CWD in free-living cervids. The Panel 
recognizes the success of the federal CWD program for game farms and envisions a comparable 
investment in the management of CWD in wildlife.  Significant investment in CWD 
management and research by federal and provincial governments, within a national framework, 
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 Chronic wasting disease (CWD) was first diagnosed in Saskatchewan in 1996 in a farm-
raised elk (wapiti).  In 2000, the disease was detected in a wild mule deer in Saskatchewan, and 
by the end of the 2003 hunting season, a total of 34 wild deer in Saskatchewan had been 
diagnosed with the CWD, the only wild deer populations in Canada thus far known to be 
affected with the disease.  Affected animals have been detected at three relatively discrete 
geographic locations, but by far the greatest number (29) have come from the Saskatchewan 
Landing Area north of Swift Current (Map). 





















 Chronic wasting disease is a newly-recognized disease of cervids with the potential to 
harm wild populations and to impose significant economic costs on Canadian society. Yet, it 
also is one of a group of diseases called transmissible spongiform encephalopathies, or TSEs, 
which are entirely new to science, and thus every aspect of CWD is shrouded in uncertainty. 
The Canadian Cooperative Wildlife Health Centre (CCWHC), an inter-agency partnership based 
at Canada’s four colleges of veterinary medicine, has a mandate to provide sound scientific 
advice to its agency partners and to the public on important wildlife disease issues. In the face of 
the current new epidemic of CWD in wild cervids in Canada, the CCWHC assembled an 
international panel of scientists (Appendix 1) with the expertise required to evaluate CWD in 
Canadian wildlife and to recommend management, surveillance and research activities that 
would have the best chance of mitigating the full range of potential negative socioeconomic 
impacts associated with CWD in wild deer and elk in Canada. The occurrence of CWD in 
farmed cervids in Canada, and potential for transmission of CWD between farmed and wild 






 The Panel was asked to make full use of its collective expertise and the published 
scientific literature on CWD, on disease management, disease surveillance and the biology of 
North American cervids.  Detailed information about the occurrence of CWD in Canada in both 
wild and domestic cervids was provided to the Panel in the form of written material from a 
range of Canadian sources (Appendices 2, 3 and 4). On 10-12 June, 2004, the Panel members 
assembled in Saskatoon. The Panel received information and questioned agency and other 
stakeholder representatives during an open forum on 10 June, and then prepared its report in 
camera on 11-12 June and through electronic exchanges thereafter.  
 
 The result of the Panel’s deliberations is presented in this report. The Panel views CWD 
in Canadian wildlife to be a serious epidemic. The report outlines the nature and scale of the 
activities required to reduce the impact of CWD in Canada, and urges a coordinated national 
approach through which all relevant jurisdictions invest collectively in a unified program of 
management, research and mitigation.   
 
 
Ted Leighton DVM, PhD  
Executive Director  
Canadian Cooperative Wildlife Health Centre 








Chronic wasting disease (CWD) was first recognized in Canada in a herd of farmed elk (Cervus 
elaphus) in 1996.  Further testing revealed that CWD was present on 40 game farms in 
Saskatchewan and three in Alberta.  CWD is a reportable disease in Canada under the Health of 
Animals Act.  Hence, an eradication program for CWD in farmed cervids was implemented in 
2000 by the Canadian Food Inspection Agency.  Results of eradication and surveillance 
activities in 2000-2004 support the view that successful eradication of CWD in farmed cervids 
is probable.  
 
In wild deer populations, CWD was detected in mule deer (Odocoileus hemionus) in 2000, with 
confirmed cases in three discrete areas of Saskatchewan.  For example, 21 mule deer with CWD 
were detected in a relative small zone in southern Saskatchewan (referenced hereafter as 
Saskatchewan Landing) during the hunting season of 2003.  However, there have been no 
confirmed cases of CWD in wild deer populations within Canada outside of Saskatchewan. 
 
The overall objective of the Panel is to provide an expert opinion on the best way to research 
and manage CWD in wild deer populations in Canada.  We hope that our report will offer 
guidance to federal and provincial regulatory agencies in drafting policies to contain or eradicate 
CWD in free-ranging deer populations. A second but equally important objective of the Panel is 
to provide a package of information to the general public about risks associated with CWD 
based on data and experience gained internationally in the last decade or so. 
 
In this report, the generic terms “deer species” or “cervids” refer to ungulate species and sub-
species within the taxonomic family Cervidae. 
 
 
2. MANDATE OF THE PANEL 
 
- To improve collective understanding of CWD in Canadian wildlife. 
 
- To review risk factors and implications of CWD to wild cervid populations, including 
future development of the disease throughout Canada. 
 
- To provide an expert opinion on the potential risks of CWD to humans. 
 
- To propose recommendations to manage impacts of CWD, focusing on surveillance and 
monitoring programs, prevention, eradication, containment, and human health. 
 
- To encourage a National and International cooperative framework to assess risks and 







3. EPIDEMIOLOGY AND MANAGEMENT OF CWD 
CWD belongs to a group of fatal, neurodegenerative disorders in humans and animals called 
transmissible spongiform encephalopathies or TSEs.  Other TSEs include scrapie in sheep, 
bovine spongiform encephalopathy (also called “mad cow disease”) in cattle, and Creutzfeldt-
Jakob disease in humans.  TSEs are thought to be caused by an abnormal form of proteinaceous 
agents called prions that are devoid of nucleic acid. Although CWD is not infectious in the 
classic sense, in practice it acts like an infectious agent.  According to the prion hypothesis, 
infection occurs by conversion of normal prion proteins (PrPc) into the disease-associated, 
misfolded form (PrPres) that is highly resistant to degradation by proteolytic enzymes.  Disease 
is characterized by slow accumulation of abnormal prions in lymphoid and nervous tissue.  
Clinical signs of the disease typically appear after >1.5 years, as accumulation of prions causes 
microscopic spongiform lesions in the brain.  Animals in the later stages of the disease exhibit 
behavioral changes and progressive loss of body condition.  The clinical signs of CWD are not 
unique however, and CWD can be confused with other diseases.There is no immune response 
produced in an affected host.  Currently there are no treatments or vaccines for prion diseases, 
and all infections are believed fatal. 
 
CWD is the only TSE agent that is transmissible in free-ranging cervid species, including elk, 
mule deer, and white-tailed deer (Odocoileus virginianus).  The disease was initially recognized 
in Colorado and Wyoming, first in captive cervids in the 1960s and subsequently in free-ranging 
cervids in 1981.  The actual length of time that CWD has been present in North American is 
unknown.  Distribution of the disease in North America is largely unknown, because adequate 
sampling and surveillance have not been conducted in most areas of the continent.  Currently, 
CWD is found in free-ranging cervids in portions of Colorado, Nebraska, South Dakota, 
Wyoming, Saskatchewan, New Mexico, Illinois, Utah, and Wisconsin.  
 
Specific details regarding the transmission of CWD remain uncertain; however, in most respects 
CWD behaves like an infectious disease.  Contact between infected and non-infected animals 
via saliva, urine, and feces are the most likely direct routes of transmission.  Transmission via 
contact between susceptible and infectious individuals probably requires more than transient 
exposure.  It is not known when an infected animal begins shedding disease-causing prions, but 
it likely occurs long before clinical signs of disease and may be progressive through the course 
of the disease.  Studies on CWD transmission in captive deer and elk indicate that lateral 
transmission (i.e., among a group of potential hosts sharing a common environment) occurs by 
direct contact and ingestion of abnormal prions.  Vertical transmission (i.e., from mother to 
offspring via placental transmission or milk) does not seem to be a major route of infection.  
Transmission occurs among susceptible cervid species and from infected cervids to the 
environment, then to susceptible animals.  However, the mechanisms for direct or 
environmental routes of transmission and their relative importance in free-ranging cervids are 
not understood.  Abnormal prion proteins have remarkable persistence in the environment and 
are highly resistant to a range of treatments that typically kill or inactivate conventional 
infectious agents.  Because CWD is readily transmitted among captive deer and elk concentrated 
in pens, it is believed that transmission is facilitated by the concentration of animals related to 
artificial feeding and baiting.  Relative susceptibility to transmission among cervids and for 
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other wildlife species has not been established.  Unlike scrapie in sheep, research indicates that 
genetic resistance in deer and elk is unlikely; however, the potential for genetic influences on 
susceptibility remains under investigation. 
 
Little is known about the rate of increase in prevalence and geographic spread of CWD or the 
factors that affect these rates.  Increases in CWD prevalence and geographic spread in Colorado 
and Wyoming have been relatively slow. Epidemiological modeling suggests that prevalence in 
Colorado and Wyoming may have increased 0.5 to 0.7% annually during the 1980s and 1990s.  
In addition, CWD has increased in prevalence and in geographic spread throughout areas in 
Colorado, Wyoming, and Nebraska despite the relatively low density of cervids present in these 
areas (2-5 animals per km2).  Although uncertainty remains about the mechanism of CWD 
spread across landscapes, it is generally believed that dispersing animals are one likely avenue 
of disease spread.  In addition, human activities, particularly translocation of captive and free-
ranging animals, have resulted in CWD range expansions, and once established, the disease may 
be maintained through environmental contamination for an unknown period of time.  Currently, 
there is no evidence that CWD will spontaneously disappear or be controlled without 
management intervention.  In contrast, there is significant potential for expansion of the 
geographic range of the disease.   
 
The likelihood of interspecies transmission of prion diseases is influenced by the degree of 
homology of the infective prion proteins (PrPres) with that of the host prion protein (PrPc), giving 
rise to the concept of a “species barrier” which must be overcome before an infective prion 
strain from one species causes disease in another species.  In addition, different strains of prions 
may occur within one animal species. At present, research on biological strain typing involves a 
variety of methods including biological models using laboratory rodents, molecular, and 
immunohistocemistry (IHC) methods.  In vitro conversion experiments indicate that CWD 
prions can convert human as well as bovine and sheep prion proteins into its abnormal 
conformer (PrPres), albeit at a very low rate.  However, this research is not conclusive because 
many other factors (e.g., dose, strain of the agent, route of exposure ) may also determine the 
level of the species barrier.  CWD has been experimentally transmitted after intracerebral 
inoculation to a number of animals, including cattle.  However, cattle did not become infected 
when exposed orally to infective prion proteins specific to CWD.  At present, it can be 
concluded that the species barrier may not completely protect other cervid species, including 
caribou and moose, from CWD. 
 
Most cases of CWD in cervids are diagnosed by post mortem laboratory testing on lymphoid or 
brain tissues.  Studies indicate that, compared to brain tissue, lymphoid tissue accumulates 
CWD prions at early stages of disease development in most cervid species.  Thus, testing 
lymphoid tissue allows for earlier detection of disease.  Current recommendations based upon 
the accumulation of CWD prions in cervid species include testing of retropharyngeal lymph 
node and brain obex (with intact dorsal motor nuclei of the vagus) for the diagnoses of CWD.  
Ante mortem diagnosis using tonsillar biopsies has also been used to detect CWD in live deer.  
Tonsillar biopsy also appears to be a valid method for detecting CWD during the incubation 
stage.  Although tonsillar biopsy may be used as an ante mortem and pre-clinical diagnosis, this 
approach requires capture of live animals, is only suitable in limited situations, and is not 
generally recommended for CWD surveillance.  Other ante mortem tests are currently under 
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investigation.  However, diagnoses of CWD using post mortem tissues rely on classical TSE test 
methods of Western blot and immunohistochemistry as reference and confirmatory tests. 
Recently, additional high-throughput assays were licensed in the United States for diagnostic 
screening for CWD in three species of cervids.  Only one of these tests has been evaluated 
satisfactorily in Canada.  
 
 
4. ORIGINS OF CWD IN CANADIAN WILDLIFE 
 
The origin of the prion strain that causes CWD in deer and elk remains unknown: whether CWD 
has always been a natural disease of native North American cervid species or is a new 
manifestation of another animal prion strain (e.g., scrapie) cannot be determined from available 
information, and may never be known with certainty.  However, based on current distribution 
and prevalence of CWD in Canada and the USA, it appears most likely that CWD was recently 
introduced into free-living cervids.  Consequently, the panel supports the management 
perspective that CWD was not present historically in free-living Canadian cervids, and thus that 
this disease is not part of native ecosystems. 
 
Published accounts, historical records, and results of ongoing epidemiological investigations 
suggest that captive, CWD-infected deer and elk were likely imported into Canada from the 
USA at least twice over the last 30 years; although not reported, additional introductions seem 
plausible.  The earliest incursion of CWD into Canada in the 1970s (or earlier) appears to have 
been confined to mule deer in a single zoo in Ontario, without further spread.  The second 
incursion in the 1980s (or earlier) began on at least one game farm in Saskatchewan where 
infected elk had been imported, with subsequent spread among game farms.  Because available 
epidemiological findings cannot explain fully all of the documented CWD outbreaks in captive 
deer and elk on Canadian game farms, other undocumented incursions and/or other sources of 
infection may have occurred in the last few decades. 
 
The known foci of CWD in free-ranging deer in Saskatchewan are most likely a result of 
unintentional spill-over from infected game farms.  As presently understood, the geographic 
pattern of CWD distribution in native deer suggests at least two independent spill-over events 
where CWD became established in local free-ranging populations: an infected game farm was 
almost certainly the source for one of these, and seems the most likely source for the other.  
Current knowledge supports the notion that CWD epidemics in free-ranging deer in Canada 
have spread geographically, and that CWD is well-established in at least one free-ranging deer 
population (Saskatchewan Landing).  There appear to be no natural barriers to further spread of 











5. POTENTIAL IMPACTS ON WILDLIFE POPULATIONS, HUNTING 
AND VIEWING OPPORTUNITIES, AND ASSOCIATED 
ECONOMIC REVENUES IN CANADA 
 
To date, natural cases of CWD have been found only in mule deer, white-tailed deer, and Rocky 
Mountain elk (Cervus elaphus nelsoni), but it is likely that subspecies of these cervid species are 
also susceptible.  Although no natural cases of CWD-affected caribou (Rangifer tarandus) or 
moose (Alces alces) have been reported, CWD recently has been induced experimentally in 
moose by ingestion of infected tissues.  Susceptibility of caribou to CWD remains unknown, but 
some level of susceptibility seems likely based on the similarities between the normal cellular 
prion protein of caribou and the normal cellular prion protein of mule deer. Although current 
CWD surveillance programs in Canada target deer and elk, moose and caribou probably should 
not be ignored because dispersal behavior of moose, and large herd sizes, seasonal aggregations 
and range fidelity of caribou suggest a high potential for CWD to spread in Canada if it were to 
be introduced into either of these species.  
 
Implications of CWD for wild populations remain unclear. The disease is fatal, and affected 
animals will invariably die because no known treatment or vaccine currently exists. Although 
time to death can vary from a few days to about a year in captive animals once clinical signs of 
CWD appear, time to death is probably shorter in free-living animals given the factors that 
affect the longevity of diseased animals in the wild.  There is no current information to suggest 
that the disease strongly affects the overall dynamics of infected populations in the short term, 
but the disease has not been observed long enough to know the ultimate population effects.  
Modeling projections from data collected in Colorado suggest that mule deer populations at the 
center of the affected area may decline in 40-50 years. However, insights from the modeling 
efforts to date are hindered by an unclear idea of how the disease is transmitted, and an 
incomplete understanding of the relationships between transmission rates and factors such as 
population density and size, age and sex structure, degree of spatial aggregation, seasonal 
movements, and social organization. Key to understanding the effects of CWD on free-living 
cervids are host densities or spatial structures at which the disease can decline in prevalence, and 
movement patterns among infected populations that may foster geographic spread.  If threshold 
densities for disease persistence are low, the host population will need to be severely reduced in 
order to restrict the spread of CWD, which may be logistically or politically infeasible.  
Complicating our understanding of the impact on CWD populations is the resilience of the 
CWD agent in the environment.  Environmental contamination may allow the disease to persist 
even with substantial herd reductions.  As we gain additional understanding of the factors that 
influence transmission, spatially explicit epidemiological models may offer further insights into 
the impacts of the disease and management approaches that can constrain its spread into new 
areas.  
 
In the immediate future, local management responses to the presence of CWD seem more likely 
to influence the demography of affected herds than the disease itself.  Limited ability to 
diagnose the infection in live animals, long incubation periods, subtle clinical signs, and the 
intensive sampling efforts required to detect the disease make it unlikely that CWD will be 
detected in free-living cervids prior to the point at which it can be eradicated without intensive 
control programs.  As a result, where cases are detected, management goals are likely to focus 
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on preventing spread, and thus will include some form of intensive control of the population or 
segments of the population.  Control efforts for cervid populations may range from selective 
removal of clinical suspects to localized reductions in areas of high CWD prevalence and/or 
adjacent buffer areas.  Where the goal is less than 50% overall population reduction, populations 
would be expected to rebound in the short-term given normal population reproduction and 
influx of animals from surrounding areas.  In addition to the direct effect on population sizes, 
intensive reduction programs could cause local shifts in animal distributions or alter movement 
patterns and migratory behavior.  Such behavioral responses may have implications not only for 
the well being of the targeted and adjacent herds, but may produce new challenges arising from 
increased trans-jurisdictional movements, differing administrative mandates, and public 
interests. Further, limitations on baiting and feeding cervids for CWD management may have 
consequences for local changes in distribution and productivity of some individuals or herds.  
 
Although herd reduction programs based on more liberal seasons and permits may initially 
increase hunting opportunities, the long-term fate of the hunting culture in the face of CWD is 
unknown. Initial observations in Canada and the USA indicate that the majority of hunters will 
continue to hunt in their traditional or preferred area and process cervid meat for eating even if 
CWD has been detected in the wild.  However, if the prevalence of CWD becomes high, results 
of a public attitudes survey in Wisconsin indicate that hunters may abandon the sport. 
Alternatively, it is feasible that hunters will request certified testing for CWD on an individual 
animal basis.  Where a diagnostic test is positive, the Wisconsin survey of public attitudes 
indicated that the majority of hunters would be concerned about eating the meat. Further, most 
governmental agencies currently advise against consuming CWD-infected meat.  No 
government programs similar to those in the game farming industry currently exist to 
compensate hunters for destruction of infected meat or other animal products.  In areas where 
management is focused on reducing the number of CWD-affected animals, these programs are 
incompatible with management of deer populations primarily for trophy hunting. Thus, in areas 
where CWD is relatively common, there is the potential that changing hunter attitudes may 
reduce the ability of managers to use harvest of cervids as an effective wildlife management 
tool.  A loss of hunting participation also would result in a loss of revenues associated with the 
sale of hunting licenses, which would have far-reaching implications for a wide variety of 
wildlife programs at both the national and provincial/territorial levels.  In 1996, Canadians spent 
over $800 million hunting wildlife with nearly two-thirds of these expenditures made by large 
game hunters. Ultimately, public perception about the safety of handling and consuming suspect 
meat in areas of endemic CWD, and the quality of the hunting experience in the face of 
eradication programs, may impact hunter participation in those areas and even in areas with no 
reported incidence of CWD.   
 
In addition to hunting, cervids are enjoyed by wildlife viewers.  Management programs directed 
at reducing free-living cervids infected with CWD, particularly those in or near provincial and 
national parks, are likely to reduce viewing opportunities and associated revenues.  
 
Secondary effects on other wildlife species from CWD-based management of cervids are of 
concern but are difficult to predict.  The most likely impacts include shifts in prey selection by 
predators (primarily wolves, cougars, coyotes or bears) and scavengers (e.g., corvids and eagles) 
and local shifts in animal-vehicle collisions, herbivory, and competition with livestock.  
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6. IMPLICATIONS OF CWD IN FREE-LIVING CERVIDS FOR FARMED 
ANIMALS IN CANADA 
 
The coexistence of CWD-affected populations of free-living cervids with free-ranging or 
winter-fed cattle on public and private lands is not likely to have a direct impact on the cattle 
industry because no cross-species transmission of CWD has been reported, nor is it believed 
likely at this time. Nevertheless, concerns over the evolving nature of the disease are likely to 
keep the attention of ranchers focused on the disease.  Although bovine spongiform 
encephalopathy (BSE) is not causally connected to CWD, occasional cases of BSE in Canadian 
or US cattle will likely stimulate questions and some level of concern about cattle exposure to 
the CWD agent.  Scrapie, a naturally occurring prion disease of domestic sheep and goats, 
occurs in both Canada and the USA and has been the focus of control programs in both 
countries.  As with BSE, scrapie has not been causally connected to CWD and occurrence of 
CWD should not hinder scrapie control efforts in Canada.  In light of strain and epidemiological 
similarities between scrapie in sheep and CWD in deer, however, relationships between scrapie 
and CWD warrant further investigation.   Secondarily, reduction in free-living cervids for CWD 
management may lead to increased predation on free-ranging cattle and sheep.    
 
In contrast, the potential reservoir of CWD in free-living cervids will likely have significant and 
far reaching impacts on the cervid farming industry.  Expansion of the industry would be 
constrained because of potential contamination in areas of infected free-living animals. Costs 
associated with fencing of new or established farms would increase dramatically.  Double 
fencing, fence heights of 10 feet or more, and increased fence inspection undoubtedly would be 
necessary to ensure no fence-line contact with infected animals or ingressions of free-living 
cervids into pens and farm facilities.  Further, fencing at these standards would need to be 
maintained for an extended time even after decontamination of CWD infected farms and 
restocking with CWD-free animals.  Because improved fencing and maintenance cannot 
guarantee farmed cervids are not subject to exposure, the game farm industry likely will be in 
jeopardy unless effective preventive treatments become available.  Even with the development 
of vaccines and ante mortem tests, the additional logistical difficulties and costs associated with 
precautionary activities to prevent infectious spread from the wild will rise significantly. In 
addition, public perception, both nationally and internationally, of the risks associated with 
game farm meat, velvet, and other products produced in areas of infected free-living cervids will 
likely impact game farms despite precautionary measures.  Currently, game farm products 
produced in Canada are exported to various countries. Based on experiences with CWD and 
other TSEs, it is likely that agricultural trade sanctions, like the current Korean ban of elk velvet 
from Canada, would contribute to making the game farming industry in Canada potentially 
unsustainable in the long-term if CWD were to become wide-spread in free-living cervids in 
Canada.  
 
Maintaining game farms in the presence of CWD in free-living cervids will require greater 
commitment of resources from governmental agencies given current regulatory responsibilities 
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and the need to compensate game ranchers in cases of depopulation.  At present, federal and 
provincial/territorial agencies jointly assume the costs associated with inspections, laboratory 
diagnostic tests, veterinary investigations, carcass disposal, depopulation, and site 
decontamination.  The number of incidences when these services are required is likely to rise 
significantly in areas with infected free-living cervids. 
 
 
7. IMPLICATIONS OF CWD IN FREE-LIVING CERVIDS FOR HUMAN 
HEALTH IN CANADA 
 
The prion strain thought to cause CWD has not been linked to cases of human illness in either 
Canada or the USA, and consuming venison from areas where CWD is present does not appear 
to increase the likelihood of people contracting sporadic Creutzfeldt-Jakob disease (CJD; a 
human prion disease).  Moreover, experimental studies have demonstrated a substantial 
molecular barrier to conversion of normal human prion proteins in the presence of CWD prion 
proteins.  Such a response is similar to the molecular barriers to human prion protein 
conversions by the prion strains that cause scrapie or bovine spongiform encephalopathy (BSE).  
Despite the reassuring nature of the findings in studies of human health risks conducted to date, 
there is public concern about the implications of human exposure to CWD and other animal 
prion diseases.  This concern, based on experiences with massive exposure of people to the BSE 
prion in the UK and other European countries that apparently led to about 150 cases of variant 
CJD, will likely influence public attitudes toward CWD for the foreseeable future.  Regardless 
of how unlikely human illness arising from CWD exposure may be, the perception that CWD 
could be a human pathogen will shape public attitudes toward hunting and consuming deer and 
elk in areas where CWD occurs.  The panel recognizes and supports international public health 
officials’ recommendations against consuming any parts of animals known to be infected with a 
prion disease. 
 
8. MANAGEMENT PERSPECTIVES 
Management options and predicted outcomes. 
CWD is the only TSE agent known to affect wild cervid populations. Whereas experience in 
managing or eradicating scrapie in domestic sheep can be applied to managing CWD in farmed 
deer and elk, there is no similar experience with TSEs in wild populations.  States such as 
Colorado and Wisconsin have recently undertaken CWD management programs aimed at 
eradicating or minimizing spread of the disease in wild cervids.  Although the prevalence (the 
proportion of the population that is affected) of CWD has been reduced in some areas, it is still 
not clear how best to manage the disease in wild populations. Results from these programs are 
still preliminary, but can be used to guide other management programs and predict outcomes.   
 
Two characteristics of this disease make it particularly difficult to manage. First, empirical data 
indicate CWD transmission can occur at low deer densities; this attribute necessitates high 
levels of population reduction or complete removal of deer in order to eradicate the disease. 
Second, evidence indicates infectious prions persist in the environment for years. Therefore, in 
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areas with high levels of environmental contamination, deer densities must be maintained at low 
levels for at least 5 to 10 years in order to ensure the disease is not introduced from the 
environment into re-established deer populations. Due to these two characteristics, once CWD 
becomes established in wild populations, eradication of CWD is difficult with current 
management options. 
 
As eradication of CWD is extremely difficult, preventing establishment of new foci of disease 
must be seen as the primary objective of any CWD management program.  All measures should 
be taken to prevent movement of potentially CWD-infected cervids or infectious material to 
new areas.  These measures should apply to both agricultural and non-agricultural 
environments.  
 
Where CWD is already established in wild populations, the management objective should be to 
reduce the prevalence of CWD in the population in order to reduce levels of environmental 
contamination, to reduce the probability and rate of spread, and to “buy time” until new 
methodological approaches for eradication are available.  In the Panel’s view, current levels of 
population reduction in CWD-infected areas of Saskatchewan will not prevent the disease from 
increasing in prevalence and spreading over time. 
  
Preliminary information from Wyoming and Colorado suggests that containment of CWD likely 
will require reducing cervid densities to well below 1-2 deer/km2 of critical habitat (i.e., winter 
range) across large areas. The area managed for reduction should consist of the area in which 
the disease has been detected, the core, and a surrounding area, or buffer zone, where deer from 
the core are likely to migrate or disperse. The size of the buffer zone must be based on 
knowledge of local movements and should ensure that the vast majority of deer moving out of 
the core area will disperse to areas where deer densities are sufficiently low that the probability 
of disease transmission would be extremely low.  Removal of females and mature males in areas 
of high infection rates appear to be specific strategies that could minimize spread. In addition, 
specific strategies to cull animals showing clinical signs and to cull dispersing animals (i.e., 
yearling bucks) also may help to reduce spread. These high levels of population reduction will 
need to be maintained until alternative strategies are available to eradicate the disease. 
 
Surveillance programs around infected areas must be sufficient to detect CWD at extremely low 
levels in order to identify new foci of disease. Complete depopulation of deer in an area around 
these foci, or so called “sparks,” has a higher probability of preventing establishment of the 
disease, if detected early.  Establishment of new endemic areas of CWD with long-term 
management programs as described above is highly undesirable. Consequently, preventing 
spread and stamping out sparks should receive the highest priority. 
 
Management programs should be seen as experiments and must be designed to monitor 
outcomes, such as changes in deer densities, alterations in the age structure of populations, 
changes in disease transmission rates, size of the affected area, changes in disease prevalence, 
etc. These monitoring programs must be consistent and long-term in order to determine which 
management strategies work and which do not. Although CWD management experiments are 
being implemented in other parts of North America, they need to be replicated in order to 
validate the results. The slow moving nature of the epidemic makes management “failure” 
 16 
 
difficult to detect and therefore monitoring programs must be carefully designed and well 
funded. Management programs should be adaptive in order to take advantage of new 
information as it becomes available. 
 
Current approaches to surveillance and risk assessments 
 
The document “Surveillance strategies for detecting chronic wasting disease in free-ranging 
deer and elk: results of a CWD surveillance workshop, Madison, Wisconsin, December 10-12, 
2002” provides an excellent overview of this topic. It is available at “http://
www.nwhc.usgs.gov/research/chronic_wasting/CWD_Surveillance_Strategies.pdf”. 
 
Current surveillance programs to detect CWD in wild cervids are primarily based on testing 
deer and elk harvested through hunting. In order to minimize the costs of CWD surveillance, 
wildlife or deer management zones with a perceived high risk of CWD are typically sampled 
more intensively; whereas, other low risk zones are sampled less intensively, if sampled at all. 
Classification of a zone as high risk is based on proximity to known cases of CWD in farmed or 
wild cervids, or proximity to game farms with a history of CWD. Although the risk factors for 
CWD are poorly understood, proximity to populations known to be infected with CWD is an 
obvious risk factor due to potential movement or dispersal of animals. Other risk factors such as 
degree of aggregation of cervids should be considered in developing surveillance programs. In 
some provinces, risk assessments have been completed but the results have not been adequately 
incorporated into surveillance programs. For example, Saskatchewan Environment proposed a 
surveillance program at the International CWD Workshop in Saskatoon, SK, August 2003, 
based on proximity to cases of CWD, density of critical deer habitat and levels of artificial 
feeding or baiting; however, this risk-based surveillance program has not been fully 
implemented. Ontario is using a clearly defined risk-based approach in its CWD surveillance 
program. The Panel strongly encourages such approaches. 
 
In several provinces, targeted surveillance of deer and elk showing signs of wasting and/or 
neurological disease is being used as a relatively inexpensive method of surveillance in low risk 
zones. Although useful, this strategy has significant limitations, especially in areas of low 
human densities where the probability of detecting animals with clinical signs is low. Results 
from this type of surveillance alone should not be relied upon to determine the occurrence of 
CWD in an area; rather, this approach should be used as a supplement to other surveillance 
methods if the goal of surveillance is to demonstrate absence of disease or early detection. 
 
Sample sizes for hunter surveillance programs are typically established to detect relatively low 
(e.g. 1%) prevalence of disease with 95% confidence within a wildlife or deer management 
zone. Areas smaller than a wildlife management zone are intensively sampled in some cases due 
to the perception that these smaller areas are at high risk of disease. Given the clustered 
distribution of CWD and its relatively slow rate of spread, sampling at smaller spatial scales is 
appropriate in many situations. A short-coming in most, if not all, of the surveillance programs 
is a lack of precise location information for all wild deer and elk tested for CWD.  Wildlife or 
deer management zones are typically too large to estimate prevalence of disease or monitor the 
introduction and spread of disease in an area. Precise location information allows spatially 




A detection threshold of 1% in areas adjacent to known CWD infected deer populations is 
insufficient if the goal is to detect newly established foci and attempt to eradicate sparks. 
Sample sizes to detect disease at levels below 1% are recommended in these areas and samples 
should be pooled for no more than 2-3 years in order to detect early spread of CWD into these 
areas. Unfortunately, required sample sizes for extremely low prevalence may exceed 
sustainable harvest levels or public support in areas where CWD is not known to already occur. 
 
Detection-based sampling should target adult animals (i.e., one year or older) as they are more 
likely to have detectable accumulations of abnormal prion proteins if they are infected. 
However, for research on the epidemiology of CWD, or for specific management needs, testing 
of fawns can be useful. 
 
 
Current and evolving methods of testing 
 
Diagnostic test procedures for detecting abnormal prion proteins in sampled individuals are 
constantly improving. Initially, diagnosis of CWD was based on observing spongiform (i.e. 
“sponge-like”) change in brain tissue with the light microscope.  However, these changes are 
only observed in animals in later stages of the disease and therefore this method does not detect 
earlier preclinical cases.  Immunohistochemical stains specific for abnormal prion proteins 
(PrPres) greatly improve the sensitivity and specificity of tests for CWD and permit early 
detections of CWD. Infection trials in mule deer and white-tailed deer have shown that 
abnormal prion proteins accumulate first in tonsil and retropharyngeal lymph nodes, followed 
by deposition in the dorsal motor nucleus of the vagal nerve in the obex region of the brain. As 
the disease progresses, abnormal prion proteins are found in other areas of the brain stem as 
well.  A similar pattern of disease progression is observed in elk, but whether this is consistent 
among individual elk is still under study. 
 
Sensitivity of the test procedure is dependant on which tissues are tested; of the three tissues 
most commonly sampled (retropharyngeal lymph node, tonsil, and medulla oblongata at the 
obex), retropharyngeal lymph nodes are the most sensitive (i.e.tests performed on this tissue 
detect earlier preclinical cases) and obex (i.e brainstem) is the least sensitive.  Surveillance 
programs should clearly state the testing procedures and the criteria used to classify an animal as 
“test negative”. These criteria should be standardized and validated amongst laboratories. In the 
past, different criteria have been used to define an animal as test negative.  Hence, caution 
should be used when interpreting historical surveillance results, especially results from different 
laboratories. Less sensitive tests reduce the probability of detecting CWD, and consequently 
negative results are less meaningful than they would be if more sensitive tests were used. 
 
The new “rapid” CWD tests detect abnormal prion proteins in unfixed tissues by using Western 
blot (WB) or enzyme-linked immunosorbent assay (ELISA) techniques. The sensitivities of 
these tests are similarly dependant on which tissues are analyzed. Sensitivities and specificities 
of these tests for a particular surveillance program should be determined and clearly stated when 
presenting results.  The rapid tests have a high sensitivity but lower specificity which leads to 
false positives. Immunohistochemistry has high sensitivity and specificity and is appropriate as 
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a secondary test in order to reject false positives identified via initial screening. Appropriate 
samples need to be collected to ensure that positives from rapid tests can be confirmed with 
immunohistochemistry. When CWD surveillance is based on testing only retropharyngeal 
lymph nodes, formalin fixed and frozen brain samples should still be collected from each animal 
in order to confirm infection in positive animals and allow for strain typing of the abnormal 




9. INFORMATION AND MANAGEMENT NEEDS FOR CWD 
 
There are substantial information gaps to be addressed before the potential impact of CWD on 
Canadian wildlife can be forecasted accurately, and effective management implemented 
accordingly.   
 
In the short term (within 1-3 years), defining the extent of the current epidemic is a key priority, 
requiring surveillance for CWD in wild cervids be timely and of the highest sensitivity.  This 
goal requires: 
• Developing better spatially explicit risk assessments to improve the detection power of 
surveillance programs. This type of risk assessment has been developed previously [e.g. 
Saskatchewan Environment, Ontario Ministry of Natural Resources], however it needs 
to be fully implemented. 
• Improving efficiency of surveillance by combining information among species and 
sources of information 
• Improving current surveillance to include the location of CWD-negative as well as 
CWD-positive animals, for both free-ranging and captive herds. 
 
Currently, short of total depopulation and/or wildlife barrier fencing, it is unknown what type of 
management intervention can reliably prevent the spatial spread of CWD in wild cervids.  
Quantitative modeling in combination with available data provides the best approach to 
exploring management scenarios.   
• Models should build on existing models (e.g., Gross & Miller 2001), as well as  critiques 
of such models (e.g., Schauber & Woolf 2003). 
• Model selection should be empirical, incorporating the latest available information 
arising from research and management of CWD in cervids. 
• Models to evaluate management interventions should be stochastic and be spatially 
explicit, including habitat-dependent movements of host animals.   
• Model predictions of the threshold population density of hosts,  or of  management 
regimes, such as  culling,  that will lead to  reduction in prevalence and spread of CWD 
and/or its eradication,  should guide management actions and monitoring in an adaptive 
management framework. (It is recognized that population densities close to zero may be 
required) 
• Models with the purpose of forecasting the impact of CWD on Canadian cervid 
populations, in the broader context, should include the interactions with large predators 




Even under the best case scenarios of the current outbreak of CWD in mule deer in the 
Saskatchewan Landing area, preliminary modeling indicates substantial reductions in deer 
population density (≤1 animal km-2 of critical habitat) will be required to have any chance of 
disease containment.  This level of population reduction likely cannot be accomplished by 
recreational hunting alone.  There is a need to: 
• Determine the rates and patterns of disease transmission and spread in order to design 
effective control strategies. 
• Obtain information on human dimensions and perceptions of CWD in Canada. 
• Explore methods for achieving a rapid (<2-3 yrs) and substantial (≤1 deer km-2) 
reduction in the population density of cervids over large areas (>1000 km2), and the 
public acceptability of which methods, if any, can meet these targets. 
 
There is a great need to better define potential host species for CWD, and more importantly, 
which hosts are most important in maintenance of CWD in an area, either individually or in 
combination with other sympatric hosts.  Research on transmission of CWD among species, 
including humans, livestock and other wildlife should include the following:   
• Continue efforts to quantify the risks posed to humans from consuming meat from the 
carcasses of CWD-infected animals. 
• Quantify both intra- and inter-specific transmission of CWD between moose and 
caribou. 
• Multi-host models should be developed to quantify the contribution of various 
transmission pathways within and among cervid species. 
• A target list of other wildlife of concern (e.g., bison, muskoxen) should be developed, 
and prioritized for research. 
 
There are several gaps in knowledge that continue to hamper understanding and management of 
CWD.  It would be extremely advantageous to: 
• Develop a rapid and inexpensive ante mortem field test for CWD. 
• Develop tests to detect and quantify environmental contamination by abnormal prion 
proteins (i.e., CWD agent). 
• Determine whether strain variation exists and can be used to assist in determining the 
origin of disease, and tracking of disease spread. 
• Better understand the routes and rates of direct and indirect transmission of CWD prions.  
This goal will require focal research studies in order to better predict CWD spread in 
wild cervid populations. Specifically, we need further studies to assess how population 
spatial structure, movement rates and other ecological factors influence the 













It is imperative that a national plan is developed for monitoring, managing and researching 
CWD in wild cervids in Canada.  The panel wishes to highlight the following conclusions, 
herein presented in point form for ease of understanding: 
 
• The panel views the CWD issue to be of national importance.  
• Unless some concerted and effective management action is undertaken in the near future, 
CWD will become widespread with the potential for major consequences to wildlife, 
game farming, and a variety of socio-economic interests in Canada.  
• The panel recognizes the success of the federal CWD program for game farms and 
recommends a comparable investment in the management of CWD in wildlife. 
• Notwithstanding the provincial jurisdiction over wildlife management, the panel sees the 
need for federal assistance in developing a national program to manage CWD in 
collaboration with provincial jurisdictions. 
• Eradication is a desirable goal but extremely difficult to achieve in wild populations 
given current knowledge, technologies, and resources. 
• Achieving a low or negligible level of prevalence of CWD is an appropriate strategy to 
reduce transmission rates, reduce the potential for spread, and to minimize the amount of 
transmissible prions in the environment. 
• The panel recognizes the core elements for managing and preventing the spread of CWD 
to include: 
o Implement comprehensive surveillance for CWD in wildlife and game farms. 
o Prevent transmission of CWD between free-living cervids and animals in game 
farms.  
o Avoid artificial animal concentrations (e.g., baiting and artificial feeding)  
o Conduct scientific investigations that guide management of CWD 
o Control populations  of free-living cervids to achieve disease management 
objectives.  
o Develop policies and regulations for animal translocations and other activities to 
prevent the spread of CWD.  
o Conduct scientific investigations to understand the epidemiology of CWD in 
wildlife populations. 
• Recognizing the uncertainties associated with CWD, managing agencies should adopt an 





The Panel feels that there is a sense of urgency in taking actions to contain or eradicate CWD in 
Canadian wild deer populations.  The Panel members are unanimous in supporting the following 







A:  Management of game farms 
 
1. Develop and implement policies to prevent transmission of CWD between game farm 
facilities and wildlife. Actions should include: 
 Do not permit new game farms in infected areas. 
 Use double fencing in infected areas.  
 Ensure previously infected farms are not accessible by wild cervids for a 
minimum of 5 years. 
 Develop policies and regulations for animal translocations that may lead to 
spread of CWD. 
 
2. Maintain current surveillance and management programs for CWD in farmed cervids. 
 
3. Conduct additional retrospective epidemiological tracing of all farms for more 
comprehensive risk assessments in cooperation with US authorities. 
 
4. Mandatory CWD testing of all cervid mortalities on game farms.  
 
5. Mandatory participation in CFIA and provincial surveillance programs for CWD.  
 
6. Any transportation permit should be approved by both the import and export authorities.  
 
7. Share information on surveillance results and epidemiological investigations among 
agencies with jurisdictions over wildlife and game farm animals in a timely fashion. 
 
B: Management of free-living cervids 
 
1. Develop and implement policies to minimize artificial aggregations of free-living cervids 
to reduce transmission of CWD. Actions should include: 
 Prevent access to hay stacks, salt blocks, and artificial water sources by 
wildlife in high risk areas. 
 Ban baiting or artificial feeding for cervids in high risk areas. 
 
2. Develop and evaluate management programs for reducing prevalence and spread of CWD 
in cervids by:  
 Eradicating “sparks” (i.e., new foci of infection) through local depopulation 
and intensification of monitoring in surrounding areas. 
 Controlling CWD in infected areas through population reduction to a target 
density of 1 cervid/km2 in “critical” habitat (i.e., winter range) with 
reassessment based on surveillance results. 
 
2. Monitoring and surveillance of CWD: 
 Develop and implement a risk-based surveillance program on a national 
scale, e.g., SK and ON models. 
 Implement an aggressive surveillance program in the next 1-3 years to 
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document the distribution of CWD in free-ranging cervids in Canada. 
 To prevent the spread of CWD, collect sample sizes in areas adjacent to 
infected areas that would allow the detection of prevalence at a level of 0.5% 
(5 infected individuals per 1000) with a 95% confidence level. The window 
of sampling can be up to 3 years. 
 Adopt standardized diagnostic testing procedures at the national level. 
 
C: Research needs 
 
1. Evaluate the distribution of abnormal prion proteins (PrPres) specific to CWD in different 
body parts of infected animals, and its implication to infectivity within a context of 
pathogenesis. 
 
2. Assess the potential for transmission of CWD within moose and caribou populations. 
 
3. Design an integrated research program to quantify the contribution of various transmission 
pathways within and among cervid species.  
 
4. Develop spatially explicit models of CWD transmission and spread to guide management 
actions and monitoring in an adaptive management framework. 
 
5. Collaborate in development and evaluation of diagnostic epidemiological tools including 




1. Expand communication tools about the CWD issues and programs, including regularly 
maintained and linked websites, fact sheets about CWD distribution, and media releases.  
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